Genascence is a clinical-stage biotechnology company that is using gene therapy to revolutionize the treatment of common musculoskeletal diseases. The company intends to tackle one of the most serious problems in medicine: osteoarthritis, which is the leading cause of disability, chronic pain, and a significant risk factor for opioid addiction